title: In patients with acute ischemic stroke, do different thrombolytic doses, agents, or routes of administration lead to different outcomes?
authors.affiliation: Department of Emergency Medicine, New York University School of Medicine, Bellevue Hospital Center, New York, NY.
authors.forename: Adaira
authors.initials: A
authors.lastname: Landry
authors.affiliation: Department of Emergency Medicine, New York University School of Medicine, Bellevue Hospital Center, New York, NY.
authors.forename: Mark
authors.initials: M
authors.lastname: Foran
authors.affiliation: Division of Emergency Medicine, University of Illinois College of Medicine at Peoria, OSF Saint Francis Medical Center, Peoria, IL.
authors.forename: Alex
authors.initials: A
authors.lastname: Koyfman
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy
chemical_list: D005343:Fibrinolytic Agents